{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:32:14Z","timestamp":1777984334507,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12126-4","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:19:40Z","timestamp":1769440780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The efficacy and safety of convalescent plasma for COVID-19 patients: a meta-analysis based on double-blinded parallel-arm randomized placebo-controlled trials"],"prefix":"10.1186","volume":"26","author":[{"given":"Ranran","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jincheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyuan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"issue":"1","key":"12126_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/20469047.2020.1781356","volume":"41","author":"N Rajapakse","year":"2021","unstructured":"Rajapakse N, Dixit D. Human and novel coronavirus infections in children: a review. Paediatrics Int Child Health. 2021;41(1):36\u201355.","journal-title":"Paediatrics Int Child Health"},{"issue":"3","key":"12126_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S2213-2600(21)00545-2","volume":"10","author":"A Alemany","year":"2022","unstructured":"Alemany A, Millat-Martinez P, Corbacho-Monn\u00e9 M, et al. High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial. Lancet Respir Med Mar. 2022;10(3):278\u201388.","journal-title":"Lancet Respir Med Mar"},{"issue":"3","key":"12126_CR3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3201\/eid2803.212299","volume":"28","author":"GC De Santis","year":"2022","unstructured":"De Santis GC, Oliveira LC, Garibaldi PMM, et al. High-Dose convalescent plasma for treatment of severe COVID-19. Emerg Infect Dis. 2022;28(3):548\u201355.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"12126_CR4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Y Chen","year":"2020","unstructured":"Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol Apr. 2020;92(4):418\u201323.","journal-title":"J Med Virol Apr"},{"key":"12126_CR5","first-page":"31","volume":"15","author":"M Franchini","year":"2021","unstructured":"Franchini M, Liumbruno GM. Convalescent plasma for the treatment of severe COVID-19. Biologics. 2021;15:31\u20138.","journal-title":"Biologics"},{"issue":"2","key":"12126_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/vox.13003","volume":"116","author":"M Franchini","year":"2021","unstructured":"Franchini M, Glingani C, Del Fante C, et al. The protective effect of O blood type against SARS-CoV-2 infection. Vox Sang Feb. 2021;116(2):249\u201350.","journal-title":"Vox Sang Feb"},{"issue":"7","key":"12126_CR7","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1469-0691.2004.00956.x","volume":"10","author":"YO Soo","year":"2004","unstructured":"Soo YO, Cheng Y, Wong R, et al. Retrospective comparison of convalescent plasma with continuing high-dose Methylprednisolone treatment in SARS patients. Clin Microbiol Infect Jul. 2004;10(7):676\u20138.","journal-title":"Clin Microbiol Infect Jul"},{"issue":"7","key":"12126_CR8","first-page":"617","volume":"23","author":"JH Ko","year":"2018","unstructured":"Ko JH, Seok H, Cho SY, et al. Challenges of convalescent plasma infusion therapy in middle East respiratory coronavirus infection: a single centre experience. AntivirTher. 2018;23(7):617\u201322.","journal-title":"AntivirTher"},{"issue":"8","key":"12126_CR9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","volume":"17","author":"TC Luke","year":"2006","unstructured":"Luke TC, Kilbane EM, Jackson JL, Hoffman SL. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med Oct. 2006;17(8):599\u2013609.","journal-title":"Ann Intern Med Oct"},{"issue":"1","key":"12126_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/infdis\/jiu396","volume":"1","author":"J Mair-Jenkins","year":"2015","unstructured":"Mair-Jenkins J, Saavedra-Campos M, Baillie JK, et al. The effectiveness of convalescent plasma and hyperimmune Immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis Jan. 2015;1(1):80\u201390.","journal-title":"J Infect Dis Jan"},{"issue":"17","key":"12126_CR11","doi-asserted-by":"publisher","first-page":"9490","DOI":"10.1073\/pnas.2004168117","volume":"117","author":"K Duan","year":"2020","unstructured":"Duan K, Liu B, Li C, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci. 2020;117(17):9490\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"12126_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/infdis\/jiaa228","volume":"222","author":"Q-L Zeng","year":"2020","unstructured":"Zeng Q-L, Yu Z-J, Gou J-J, et al. Effect of convalescent plasma therapy on viral shedding and survival in patients with coronavirus disease 2019. J Infect Dis. 2020;222(1):38\u201343.","journal-title":"J Infect Dis"},{"key":"12126_CR13","unstructured":"Bar KJ, Shaw PA, Choi GH, et al. A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia. J Clin Invest. 2021 Dec 15;131(24)."},{"key":"12126_CR14","unstructured":"O\u2019Donnell MR, Grinsztejn B, Cummings MJ, et al. A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19. J Clin Invest. 2021 Jul 1;131(13)."},{"key":"12126_CR15","unstructured":"Sullivan DJ, Gebo KA, Shoham S, et al. Randomized controlled trial of early outpatient COVID-19 treatment with high-titer convalescent plasma. medRxiv. 2021 Dec 21."},{"key":"12126_CR16","doi-asserted-by":"publisher","first-page":"660688","DOI":"10.3389\/fmed.2021.660688","volume":"8","author":"DF Barreira","year":"2021","unstructured":"Barreira DF, Louren\u00e7o RA, Calisto R, Moreira-Gon\u00e7alves D, Santos LL, Videira PA. Assessment of the safety and therapeutic benefits of convalescent plasma in COVID-19 treatment: A systematic review and Meta-Analysis. Front Med (Lausanne). 2021;8:660688.","journal-title":"Front Med (Lausanne)"},{"key":"12126_CR17","doi-asserted-by":"publisher","first-page":"624924","DOI":"10.3389\/fmed.2021.624924","volume":"8","author":"V Bansal","year":"2021","unstructured":"Bansal V, Mahapure KS, Mehra I, et al. Mortality benefit of convalescent plasma in COVID-19: A systematic review and Meta-Analysis. Front Med (Lausanne). 2021;8:624924.","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"12126_CR18","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/CCM.0000000000005066","volume":"1","author":"E Bennett-Guerrero","year":"2021","unstructured":"Bennett-Guerrero E, Romeiser JL, Talbot LR, et al. Severe acute respiratory syndrome coronavirus 2 convalescent plasma versus standard plasma in coronavirus disease 2019 infected hospitalized patients in new york: A Double-Blind randomized trial. Crit Care Med Jul. 2021;1(7):1015\u201325.","journal-title":"Crit Care Med Jul"},{"key":"12126_CR19","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","volume":"21","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. Bmj Sep. 2017;21:358:j4008.","journal-title":"Bmj Sep"},{"issue":"7","key":"12126_CR20","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"21","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med Jul. 2009;21(7):e1000097.","journal-title":"PLoS Med Jul"},{"key":"12126_CR21","first-page":"Ed000142","volume":"3","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev Oct. 2019;3:10:Ed000142.","journal-title":"Cochrane Database Syst Rev Oct"},{"key":"12126_CR22","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj Aug. 2019;28:366:l4898.","journal-title":"Bmj Aug"},{"issue":"5","key":"12126_CR23","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1398-9995.2010.02530.x","volume":"66","author":"JL Bro\u017cek","year":"2011","unstructured":"Bro\u017cek JL, Akl EA, Compalati E, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy May. 2011;66(5):588\u201395.","journal-title":"Allergy May"},{"issue":"5","key":"12126_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1398-9995.2009.01973.x","volume":"64","author":"JL Brozek","year":"2009","unstructured":"Brozek JL, Akl EA, Alonso-Coello P, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy May. 2009;64(5):669\u201377.","journal-title":"Allergy May"},{"issue":"2","key":"12126_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1001\/jamainternmed.2021.6850","volume":"182","author":"MB Ortigoza","year":"2022","unstructured":"Ortigoza MB, Yoon H, Goldfeld KS, et al. Efficacy and safety of COVID-19 convalescent plasma in hospitalized patients: A randomized clinical trial. JAMA Intern Med. 2022;182(2):115\u201326.","journal-title":"JAMA Intern Med"},{"issue":"7","key":"12126_CR26","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJMoa2031304","volume":"384","author":"VA Simonovich","year":"2021","unstructured":"Simonovich VA, Pratx LDB, Sabana P, et al. A randomized trial of convalescent plasma in Covid-19 severe pneumonia. N Engl J Med Feb. 2021;384(7):619\u201329.","journal-title":"N Engl J Med Feb"},{"issue":"1","key":"12126_CR27","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1038\/s41598-022-06221-8","volume":"15","author":"K van den Berg","year":"2022","unstructured":"van den Berg K, Glatt TN, Vermeulen M, et al. Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial). Sci Rep Feb. 2022;15(1):2552.","journal-title":"Sci Rep Feb"},{"key":"12126_CR28","doi-asserted-by":"crossref","unstructured":"Balde\u00f3n ME, Maldonado A, Ochoa-Andrade M, et al. Effect of convalescent plasma as complementary treatment in patients with moderate COVID-19 infection. Transfus Med. 2022 Jan 9.","DOI":"10.1111\/tme.12851"},{"issue":"7","key":"12126_CR29","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa2033700","volume":"384","author":"R Libster","year":"2021","unstructured":"Libster R, Marc GP, Wappner D, et al. Early high-titer plasma therapy to prevent severe Covid-19 in older adults. N Engl J Med. 2021;384(7):610\u20138.","journal-title":"N Engl J Med"},{"issue":"11","key":"12126_CR30","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.5005\/jp-journals-10071-24023","volume":"25","author":"S Sarkar","year":"2021","unstructured":"Sarkar S, Khanna P, Singh AK. Convalescent Plasma-A light at the end of the tunnel: A systematic review and Meta-analysis of randomized controlled trials. Indian J Crit Care Med Nov. 2021;25(11):1292\u2013300.","journal-title":"Indian J Crit Care Med Nov"},{"issue":"2","key":"12126_CR31","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/jmv.26408","volume":"93","author":"S Sarkar","year":"2021","unstructured":"Sarkar S, Soni KD, Khanna P. Convalescent plasma is a clutch at straws in COVID-19 management! A systematic review and meta-analysis. J Med Virol Feb. 2021;93(2):1111\u20138.","journal-title":"J Med Virol Feb"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12126-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12126-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12126-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:19:42Z","timestamp":1769440782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12126-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12126"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12126-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4741126\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as this meta-analysis is a secondary study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors had full access to all the data associated with this meta-analysis and made the final decision to publish it. Consent for the publication of identifying images or other personal or clinical details that compromise anonymity: Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}